EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Histone mutations in cancer

Kimberly N Espinoza Pereira, Jixiu Shan, Jonathan D Licht, Richard L Bennett iD

Biochemical Society Transactions · 31.10.2023 · 51 (5) · 1749-1763

DOI: 10.1042/bst20210567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Society Transactions, online erschienen am 18.09.2023. Verfasst von Kimberly N Espinoza Pereira und 3 weiteren Autor:innen. Beteiligte Einrichtung: UF Health Cancer Center, University of Florida, Gainesville, FL 32610, U.S.A. Hauptthemen laut MEDLINE: Histones, Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genes encoding histone proteins are recurrently mutated in tumor samples, and these mutations may impact nucleosome stability, histone post-translational modification, or chromatin dynamics. The prevalence of histone mutations across diverse cancer types suggest that normal chromatin structure is a barrier to tumorigenesis. Oncohistone mutations disrupt chromatin structure and gene regulatory mechanisms, resulting in aberrant gene expression and the development of cancer phenotypes. Examples of oncohistones include the histone H3 K27M mutation found in pediatric brain cancers that blocks post-translational modification of the H3 N-terminal tail and the histone H2B E76K mutation found in some solid tumors that disrupts nucleosome stability. Oncohistones may comprise a limited fraction of the total histone pool yet cause global effects on chromatin structure and drive cancer phenotypes. Here, we survey histone mutations in cancer and review their function and role in tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesNeoplasmsHumansChildNucleosomesMutationChromatinCarcinogenesisCell Transformation, Neoplastic

Stichwörter der Autor:innen

cancerchromatinhistonespoint mutations

Substanzen

HistonesNucleosomesChromatin

Autor:innen und Institutionen

  • UF Health Cancer Center, University of Florida, Gainesville, FL 32610, U.S.A.

ORCID-Profile: Richard L Bennett

Förderung

  • NCI NIH HHS

Zitieren

APA

Espinoza Pereira, K. N., Shan, J., Licht, J. D., & Bennett, R. L. (2023). Histone mutations in cancer. Biochemical Society Transactions, 51(5), 1749-1763. https://doi.org/10.1042/bst20210567

Vancouver

Espinoza Pereira KN, Shan J, Licht JD, Bennett RL. Histone mutations in cancer. Biochemical Society Transactions. 2023;51(5):1749-1763. doi:10.1042/bst20210567

BibTeX
@article{EspinozaPereira2023,
  author = {Espinoza Pereira, Kimberly N and Shan, Jixiu and Licht, Jonathan D and Bennett, Richard L},
  title = {Histone mutations in cancer},
  journal = {Biochemical Society Transactions},
  year = {2023},
  volume = {51},
  number = {5},
  pages = {1749--1763},
  doi = {10.1042/bst20210567}
}
Kostenlos starten →